Congestive heart failure complicating non-ST segment elevation acute coronary syndrome: incidence, predictors, and clinical outcomes

Author： Mehta Shamir R Eikelboom John W Demers Catherine Maggioni Aldo P Commerford Patrick J Yusuf Salim

Publisher： NRC Research Press

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.83, Iss.1, 2005-01, pp. : 98-103

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical use of enoxaparin in the management of non-ST segment elevation acute coronary syndromes

By Galla John M Mahaffey Kenneth W

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 7, 2005-06 ,pp. : 1241-1251

Informa Healthcare

Access to resources Recommend Favorite

Evaluating the Potential Economic Attractiveness of New Therapies in Patients with Non-ST Elevation Acute Coronary Syndrome

By Eisenstein E.L. Peterson E.D. Jollis J.G. Tardiff B.E. Califf R.M. Knight J.D. Mark D.B.

PharmacoEconomics, Vol. 17, Iss. 3, 2000-03 ,pp. : 263-272

Adis International

Access to resources Recommend Favorite

Clinical policy for non-ST segment elevation ACS revised by ACEP

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 514, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Fondaparinux: A Pharmacoeconomic Review of its Use in the Management of Non-ST-Segment Elevation Acute Coronary Syndrome

By McKeage Kate Lyseng-Williamson Katherine A.

PharmacoEconomics, Vol. 28, Iss. 8, 2010-08 ,pp. : 687-698

Adis International

Access to resources Recommend Favorite

Paclitaxel: Acute coronary syndrome with ST-segment elevation: case report

Reactions Weekly, Vol. 1, Iss. 1268, 2009-01 ,pp. : 23-24

Adis International

Access to resources Recommend Favorite